This study will be a single-site, controlled, unblinded study at the University of Wisconsin to examine changes in the electroencephalogram during anesthesia and waking.
\* 20 subjects will be recruited per drug, and subjects can be recruited to undergo multiple sedation protocols. Screening: Subjects will respond to the volunteer posts for the study by calling into a study specific phone number. They will complete a phone screening to determine basic eligibility for the study. At the beginning of the sedation session, participants will affirm that in the interval since their baseline visit, they have not acquired any of the cited exclusion criteria that would preclude participation. A review of these exclusion criteria will be completed by the Anesthesiologist. A standard pre-anesthetic assessment will be performed, including confirmation of NPO status, and documented using the standard Department of Anesthesiology pre-operative evaluation form. The first sedative will be dexmedetomidine followed by ketamine, propofol and then midazolam (dependent on the availability of the drugs). Total enrollment in the study will be up to 80 subjects. Each sedation experiment will occur on separate days at least 28 days apart, if the subject chooses to participate in more than one session.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
35
20 participants will be administered Dexmedetomidine.
20 participants will be administered Ketamine.
20 participants will be administered Propofol.
UW Hospital and Clinics
Madison, Wisconsin, United States
Occipital Delta Power Spectral Density by Conscious State and Study Group.
The difference in spontaneous EEG slow wave activity over posterior cortex between states of consciousness measured with high-density EEG equipment and reported in spectral power in the delta band (1-4 Hz) at electrode Oz. Disconnected conscious experience (dreaming), connected conscious experience (awareness of the external world), and unconsciousness (no report) was assessed when participants were roused from sedation or sleep.
Time frame: Intraoperative (During sedation-- up to 8 hours)
Number of Instances of Disconnected Conscious Experience (Dreaming) vs Connected Conscious Experience (Awareness of External World).
The number of instances of disconnected conscious experience (dreaming) versus connected conscious experience (awareness of the external world) during sedation is measured by subject self-report at the time of researcher initiated inquiry.
Time frame: Intraoperative (During sedation-- up to 8 hours)
Effect of Study Drug on Ability to Correctly Identify Shapes/Images
The ability to identify shapes/images in visual illusions measured by the NIH Toolbox. Will be reported by a computed score from NIH Toolbox for the Dimensional Change Card Sort Test (DCCS) and the Flanker Inhibitory Control \& Attention Test (Flanker). Both Flanker and DCCS use a 2-vector scoring method that takes accuracy and reaction time (if accuracy \>=80%) into account, resulting in a computed score that can range in value from 0-10. A higher score indicates better performance on the test.
Time frame: Intraoperative (During sedation-- up to 8 hours)
Effect of Study Drug on Ability to Correctly Identify Images
The ability to match sounds and images measured by the predictive coding task. Will be reported by a proportion correct as a decimal.
Time frame: Intraoperative (During sedation-- up to 8 hours)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
20 participants will be administered Midazolam.
Effect of Study Drug on Ability to Form Implicit Memory
Subjects will have a list of words read to them while under sedation and their ability to hear these words and form implicit memories of them will be assessed using a two-alternative forced choice task. Results will be reported as the average number of correct responses out of sixteen.
Time frame: Intraoperative (During sedation-- up to 8 hours)